Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Ciudad Autonoma De Buenos Aire, Argentina
Doctor in Buenos Aires
Av. Rivadavia 4190, C1205AAO CABA
About Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
During the past decade, Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps
2018-11-27
2022-01-19
Completed
332
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
2019-02-18
2020-04-08
Completed
287
Oral Immunotherapy for Desensitization in Children, Adolescents, and Young Adults With Hen Egg Allergy
2019-08-20
2020-12-28
Terminated
15
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
2020-09-08
2021-04-13
Completed
122
Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough
2020-10-02
2021-07-23
Completed
310
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
According to Clinical.Site data, the most researched conditions in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are
"Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" in a lesser frequency.
Clinical Trials Intervention Types at Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Most popular intervention types in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Tirzepatide" (3 trials), "Dulaglutide" (2 trials), "Insulin Glargine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
The vast majority of trials in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff" are
4 trials for "All" genders.
Clinical Trials Status at Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
Currently, there are NaN active trials in "Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".